Copyright: ©Author(s) 2026.
World J Transl Med. Jul 28, 2026; 12(2): 122755
Published online Jul 28, 2026. doi: 10.5528/wjtm.122755
Published online Jul 28, 2026. doi: 10.5528/wjtm.122755
Table 1 Common nephrological causes for hematuria: Clinical features and suggested management for physicians
| Renal diagnosis | Urine findings (hematuria and proteinuria) | Systemic/extra-renal features | Family history | Suggested next step |
| Primary glomerulonephritis | ||||
| IgA nephropathy | Microhematuria ± episodic macroscopic hematuria (synpharyngitic); mild-moderate proteinuria | Nil specific; often follows upper respiratory tract infection | May be positive | Nephrology referral; urine ACR; serum creatinine/eGFR |
| Thin basement membrane nephropathy | Persistent microhematuria; proteinuria absent or trace | Nil | Positive - first-degree relatives with hematuria | Nephrology referral; genetic testing (COL4A3/COL4A4) if proteinuria or eGFR decline develops |
| Alport syndrome (X-linked/AR/AD) | Persistent microhematuria + proteinuria; RBC casts possible | Sensorineural hearing loss; anterior lenticonus; macular flecks | Strongly positive - renal failure, dialysis, or transplant in family | Nephrology referral; genetic testing (COL4A3/ COL4A4/COL4A5); audiology; ophthalmology review |
| FSGS | Microhematuria + significant proteinuria (nephrotic range possible) | Nephrotic syndrome, hypertension | May be positive (genetic FSGS) | Nephrology referral; urine PCR/ACR; renal biopsy likely needed |
| Membranous nephropathy | Microhematuria + sub-nephrotic proteinuria | Nephrotic syndrome and/or thromboembolic events | Usually, negative | Nephrology referral; anti-PLA2R antibody; urine ACR |
| Mesangioproliferative GN | Persistent microhematuria + proteinuria | Nil specific | Usually, negative | Nephrology referral; urine ACR; serum creatinine/eGFR; complement levels |
| CFHR5 nephropathy | Persistent microhematuria ± synpharyngitic macroscopic hematuria; mild proteinuria | Nil specific | Strongly positive | Nephrology referral; complement studies; genetic testing (CFHR5) |
| Secondary glomerulonephritis | ||||
| Lupus nephritis (SLE) | Microhematuria + proteinuria + RBC casts | Malar rash; arthritis; serositis; oral ulcers; photosensitivity; pancytopenia, organomegaly, lymphadenopathy, hypertension | May be positive | Nephrology referral; ANA, anti-dsDNA, complement (C3/C4) |
| ANCA-associated Vasculitis (GPA/MPA) | Microhematuria + proteinuria; RBC casts; rapidly declining eGFR | Sinusitis; hemoptysis; pulmonary infiltrates; purpura | Usually, negative | Urgent nephrology referral; ANCA (PR3/MPO); chest imaging |
| Anti-GBM disease | Macroscopic or microscopic hematuria + heavy proteinuria; RBC casts | Hemoptysis; rapidly progressive renal failure | Usually, negative | Emergency nephrology referral; anti-GBM antibody; CXR |
| IgA vasculitis | Microhematuria ± proteinuria | Palpable purpura (lower limbs/buttocks); arthralgia; colicky abdominal pain | Usually, negative | Nephrology referral; clinical diagnosis; urine monitoring |
| Post-infectious glomerulonephritis | Macroscopic or microscopic hematuria + proteinuria; RBC casts; oliguria | Preceding streptococcal throat or skin infection (1-3 weeks prior) | Usually, negative | Nephrology referral; ASO titre; C3 (low); C4 (normal) |
| Complement-mediated | ||||
| C3 glomerulopathy (C3GN/DDD) | Microhematuria + proteinuria; RBC casts | Nil specific; lipodystrophy in DDD | May be positive (complement gene variants) | Nephrology referral; C3/C4; complement factor H; genetic complement panel |
| Atypical HUS | Hematuria + proteinuria; rapidly falling eGFR | Thrombocytopenia; microangiopathic hemolytic anemia; hypertension | May be positive (CFH, CFI gene variants) | Emergency nephrology referral; FBC; LDH; complement studies |
| Hereditary/genetic | ||||
| ADPKD | Micro or macroscopic hematuria; proteinuria mild or absent | Flank pain; hypertension; enlarged kidneys; hepatic cysts | Strongly positive - autosomal dominant pattern | Renal ultrasound; nephrology referral; PKD1/PKD2 genetic testing if required |
| Congenital anomalies of kidney and urinary tract | Microhematuria; proteinuria variable | Structural anomaly on imaging; recurrent UTIs | May be positive | Renal ultrasound; nephrology referral; genetic testing if syndromic |
| Tubulointerstitial | ||||
| AIN | Microhematuria + mild proteinuria; eosinophiluria (variable) | Drug exposure (NSAIDs, antibiotics, PPIs); fever; rash; rising creatinine | Usually, negative | Nephrology referral; stop offending drug; urgent review if creatinine rising |
| Oxalate nephropathy | Microhematuria + oxalate crystals on urinalysis; mild proteinuria | High oxalate diet; bariatric surgery history; prior jejunoileal bypass | May be positive (primary hyperoxaluria) | Nephrology referral; 24-hour urine oxalate; genetic testing if primary hyperoxaluria suspected |
Table 2 Pre-test counselling framework for genetic testing in glomerular hematuria
| Counselling topic | Standard patient-facing counselling script |
| Why the test is being done? | This test looks for differences in your genes that can cause kidney disease. We are checking these differences to see if they can explain your symptoms and help us determine best way to care for you |
| What the results may show? | |
| Positive - pathogenic/Likely pathogenic | This means we found a genetic difference that causes disease and explains your condition |
| Negative - benign/Likely benign | This means no known disease- causing difference was found. It doesn't always rule out a genetic cause, but we didn’t find one today |
| Inconclusive | We found a genetic difference, but we aren’t sure yet if it’s the cause of the disease or just a normal variation |
| So what’s next? How it affects treatment or family | Finding a genetic cause can change your treatment plan, such as suggesting different medication or extra screenings. Because this condition runs in the family it may also help us identify if your relatives are at risk |
- Citation: Bashyam S, Shankar M. Beyond the bladder: Recognising glomerular hematuria and the role of genetic testing in clinical practice. World J Transl Med 2026; 12(2): 122755
- URL: https://www.wjgnet.com/2220-6132/full/v12/i2/122755.htm
- DOI: https://dx.doi.org/10.5528/wjtm.122755